Leaders of an ongoing pancreatic cancer clinical trial known as the Individualized Molecular Pancreatic Cancer Therapy or 'IMPaCT' trial, have been learning ways to bring about about a new paradigm of personalized cancer care for pancreatic cancer and other aggressive cancer types.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1bkTNJk
No comments:
Post a Comment